Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Free Cash Flow (2016 - 2025)

Macrogenics (MGNX) has disclosed Free Cash Flow for 14 consecutive years, with $41.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Free Cash Flow rose 206.77% to $41.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$83.0 million, a 21.15% decrease, with the full-year FY2025 number at -$83.0 million, down 21.15% from a year prior.
  • Free Cash Flow was $41.1 million for Q4 2025 at Macrogenics, up from -$28.9 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $62.7 million in Q3 2024 to a low of -$60.4 million in Q4 2021.
  • A 5-year average of -$23.6 million and a median of -$32.2 million in 2023 define the central range for Free Cash Flow.
  • Biggest YoY gain for Free Cash Flow was 280.22% in 2024; the steepest drop was 1727.81% in 2024.
  • Macrogenics' Free Cash Flow stood at -$60.4 million in 2021, then skyrocketed by 143.0% to $26.0 million in 2022, then crashed by 214.02% to -$29.6 million in 2023, then dropped by 29.94% to -$38.5 million in 2024, then surged by 206.77% to $41.1 million in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Free Cash Flow are $41.1 million (Q4 2025), -$28.9 million (Q3 2025), and -$47.7 million (Q2 2025).